Jones Trading analyst Soumit Roy downgraded aTyr Pharma (NASDAQ: ATYR) from Buy to Hold.The analyst comments "Why we were wrong ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE